Trial
NCT01371240
Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University Hospitals Cleveland Medical Center
Collaborators
Repligen Corporation
Condition
Pancreas Cancer
Intervention
Secretin Synthetic Human (RG1068)
Why stopped
Study never started
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-06-16